Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2026-02-27 @ 12:48 AM
Study NCT ID:
NCT02280434
Status:
COMPLETED
Last Update Posted:
2016-11-03
First Post:
2014-10-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Study Accessing the Safety and Tolerability of CBP-307
Sponsor:
Connect Biopharm LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-11
Start Date Type:
None
Primary Completion Date:
2015-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-08
Completion Date Type:
ACTUAL
First Submit Date:
2014-10-20
First Submit QC Date:
None
Study First Post Date:
2014-10-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-11-01
Last Update Post Date:
2016-11-03
Last Update Post Date Type:
ESTIMATED